Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

Arch Med Sci. 2019 Nov 3;16(6):1496-1500. doi: 10.5114/aoms.2019.89217. eCollection 2020.
No abstract available